ViroMissile
CompanyUnited States
ViroMissile develops one asset, in phase 1 (IDOV-2 in advanced solid tumor). Mostly other; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 1
- 0
- Trials
- 0
- Signals
Pipeline
1Intravenously deliverable oncolytic virus for cancer immunotherapy.
Phase 1, Other, advanced solid tumor, solid tumor
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies6